Wegovy First Month Results: Week-by-Week Appetite Shifts, Weight Loss, and Side Effects

What the 0.25 mg Starter Month Is Designed to Do

When starting Wegovy (semaglutide), social media highlights can create pressure to expect dramatic transformations in 30 days. Clinically, the first four weekly 0.25 mg injections serve as an acclimation phase—introducing GLP-1 signaling to hypothalamic satiety centers and slowing gastric emptying gradually so you avoid severe nausea.

Week-by-Week Breakdown of Month 1

• Week 1 — First injection & subtle satiety: Semaglutide reaches peak plasma levels 1–3 days post-dose. Some patients feel noticeably less preoccupied with snacking right away; others feel totally normal.
• Week 2 — Quieter ‘food noise’: Smaller portions start feeling genuinely satisfying, and cravings for rich, sugary, or fried foods often diminish.
• Week 3 — Steady plasma build & GI check-in: Because semaglutide has a 7-day half-life, background levels accumulate across weeks 1–4. Mild fullness, burping, or slower bowel habits are easiest to manage now with water and soluble fiber.
• Week 4 — Progress review & titration check: You and your clinician evaluate waist measurements, energy, GI comfort, and readiness to step up to 0.5 mg in Month 2.

Realistic Scale Numbers & Habits That Amplify Results

In pivotal STEP clinical trials, average weight reduction after the first 4 weeks was roughly 2% to 3% of baseline weight (about 4–7 lbs for a 220-lb adult), accelerating steadily across months 3 through 12 toward ~15% total weight loss. Support Month 1 by eating protein first at every meal, sipping 64–80+ oz of water daily, avoiding heavy late-night meals, and walking or strength-training regularly. Start or personalize your program at Amble Weight Loss.